Initial Therapeutics Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Initial Therapeutics is a biotechnology company focused on discovering and developing a new class of small-molecule medicines aimed at preventing the formation of pathogenic proteins at their earliest stages. Its work targets mechanisms that act before proteins are fully formed, distinguishing it from approaches that intervene after maturation. The company operates from South San Francisco, California, and maintains a relatively small team to pursue its focused scientific program.